Bartosz Korczowski
Overview
Explore the profile of Bartosz Korczowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Danese S, Fiorino G, Vicaut E, Paridaens K, Ugur A, Clark B, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274360
Current management of mild-to-moderate ulcerative colitis (UC) involves monitoring clinical markers of disease activity, such as stool frequency (SF) and rectal bleeding (RB), and adjusting treatment accordingly. Our aim was...
2.
Dembinski L, Grzybowska-Chlebowczyk U, Toporowska-Kowalska E, Walkowiak J, Gladysiewicz B, Dadalski M, et al.
J Infect Public Health
. 2024 Jan;
17(3):396-400.
PMID: 38246113
Background: Gastrointestinal endoscopy is a procedure that carries an increased risk of transmission of SARS-CoV-2 infection to medical staff. In patients, COVID-19 is a risk factor for adverse events of...
3.
Miesbach W, Halimeh S, Platokouki H, Podolak-Dawidziak M, Zdziarska J, Korczowski B, et al.
Haemophilia
. 2023 Nov;
30(1):236-240.
PMID: 38030954
No abstract available.
4.
Croft N, Korczowski B, Kierkus J, Caballero B, Thakur M
EClinicalMedicine
. 2023 Oct;
65:102232.
PMID: 37855022
Background: Previous studies have demonstrated the tolerability and efficacy of multimatrix mesalamine in inducing and maintaining remission in adults with mild-to-moderate ulcerative colitis (UC). We evaluated the safety and efficacy...
5.
Wisniowska-Szurlej A, Woloszyn N, Brozonowicz J, Ciapala G, Pietryka K, Grzegorczyk J, et al.
Med Sci Monit
. 2023 Jul;
29:e940511.
PMID: 37452491
BACKGROUND Stroke is a leading cause of long-term disability, often resulting in impaired mobility and gait abnormalities, necessitating effective rehabilitation approaches. Robotic-assisted gait training (RAGT) offers precise control and intensive,...
6.
Ledder O, Woynarowski M, Kaminska D, Lazowska-Przeorek I, Pieczarkowski S, Romano C, et al.
J Pediatr Gastroenterol Nutr
. 2023 Jun;
77(3):401-406.
PMID: 37276149
Objectives: Iatrogenic viscus perforation in pediatric gastrointestinal endoscopy (GIE) is a very rare, yet potentially life-threatening event. There are no evidence-based recommendations relating to immediate post-procedure follow-up to identify perforations...
7.
Korczowski B, Farrell C, Falone M, Blackman N, Rodgers T
Pediatr Res
. 2023 May;
94(4):1547-1554.
PMID: 37208431
Background: Iron deficiency is the primary cause of anemia in children. Intravenous (IV) iron formulations circumvent malabsorption and rapidly restore hemoglobin. Methods: This Phase 2, non-randomized, multicenter study characterized the...
8.
Zhang W, Scalori A, Fuh F, McBride J, She G, Kierkus J, et al.
Inflamm Bowel Dis
. 2022 Apr;
28(10):e143.
PMID: 35366308
No abstract available.
9.
Hyams J, Turner D, Cohen S, Szakos E, Kowalska-Duplaga K, Ruemmele F, et al.
J Crohns Colitis
. 2022 Mar;
16(8):1243-1254.
PMID: 35301512
Background And Aims: To date, there are no systematic pharmacokinetic [PK] data on vedolizumab in paediatric inflammatory bowel disease [IBD]. We report results from HUBBLE, a dose-ranging, phase 2 trial...
10.
Mahlangu J, Karim F, Stasyshyn O, Korczowski B, Salazar B, Lucas S, et al.
Res Pract Thromb Haemost
. 2022 Feb;
6(2):e12665.
PMID: 35224416
Background: rVIII-SingleChain is a recombinant single-chain factor VIII used to treat people with hemophilia A. Objectives: The aim of this extension study was to investigate the long-term safety and efficacy...